Online Database of Chemicals from Around the World

(alphaR)-alpha-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]cyclohexaneacetamide
[CAS# 952021-60-2]

List of Suppliers
Taizhou Crene Biotechnology Co., Ltd. China Inquire  
+86 (576) 8881-3233
8820-5808
+86 13396860566
order@pharm-intermediates.com
QQ chat
Chemical manufacturer since 2011
chemBlink standard supplier since 2009
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Synkinase China Inquire  
+86 (21) 5072-0296
service@synkinase.com
Chemical manufacturer
chemBlink standard supplier since 2013
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
Santa Cruz Biotechnology, Inc. USA Inquire  
+1 (831) 457-3800
scbt@scbt.com
Chemical manufacturer
Complete supplier list of (alphaR)-alpha-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]cyclohexaneacetamide
Identification
Classification Biochemical >> Inhibitor >> Cell cycle >> Chk inhibitor
Name (alphaR)-alpha-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]cyclohexaneacetamide
Molecular Structure CAS # 952021-60-2, (alphaR)-alpha-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]cyclohexaneacetamide
Molecular Formula C22H25N7O2
Molecular Weight 419.48
CAS Registry Number 952021-60-2
Properties
Density 1.56
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for (alphaR)-alpha-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]cyclohexaneacetamide
Related Products
6-Amino-3,4-dihydro-1(2H)-isoquinolinone  6-Amino-7,9-dihydro-2-(2-methoxyethoxy)-9-(phenylmethyl)-8H-purin-8-one  2-Amino-1,7-dihydro-7-(methoxymethyl)-4H-pyrrolo[2,3-d]pyrimidin-4-one  2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide  (alphaS)-alpha-Amino-2,3-dihydro-5-(2-methoxy-2-oxoethyl)-7-nitro-delta-oxo-1H-indole-1-pentanoic acid  (6S)-3-Amino-4,6-dihydro-6-(1-methylethyl)pyrrolo[3,4-c]pyrazole-5(1H)-carboxylic acid tert-butyl ester  4-Amino-2,4-dihydro-5-(1-methylethyl)-3H-1,2,4-triazol-3-one  5-Amino-1,3-dihydro-1-methyl-2H-indol-2-one  N-[4-[2-(2-Amino-4,7-dihydro-1-methyl-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid  2-Amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]-pyrazolo[1,5-a]pyrimidine-3-carboxamide  2-Amino-3,7-dihydro-3-methyl-4H-pyrrolo[2,3-d]pyrimidin-4-one  2-Amino-1,7-dihydro-1-methyl-4H-pyrrolo[2,3-d]pyrimidin-4-one  2-Amino-1,9-dihydro-9-[(1R,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  2-Amino-1,9-dihydro-9-[(1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  2-Amino-1,9-dihydro-9-[(1S,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  2-Amino-1,9-dihydro-9-[(1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  rel-2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  2-Amino-1,9-dihydro-9-[(1S,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one  7-Amino-3-[[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl)thio]methyl]cephalosporanic acid